Search Within

Head and Neck Service

Formats
  1. Journal Article (412)
  2. Meeting Abstract (361)
  3. Book Section (21)
  4. Review (19)
  5. Editorial (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Correspondence (5)
  9. Book Whole (1)
  10. Conference Paper (1)
  11. Miscellaneous (1)
Groups
  1. Solid Tumor Oncology Division (841)
  2. Department of Medicine (835)
  3. Surgery (363)
  4. Head and Neck Surgery (342)
  5. Radiation Oncology, Department of (314)
  6. Survivorship Research (312)

More Groups

People
  1. David Pfister (389)
  2. Eric Sherman (346)
  3. Nancy Lee (270)
  4. Alan Ho (243)
  5. Nadeem Riaz (163)
  6. Richard Wong (143)

More People

Years
  1. 2025 (19)
  2. 2024 (72)
  3. 2023 (55)
  4. 2022 (57)
  5. 2021 (58)
  6. 2020 (67)

More Years

Publications
  1. Journal of Clinical Oncology (208)
  2. International Journal of Radiation Oncology, Biology, Physics (140)
  3. Annals of Oncology (43)
  4. Cancer (33)
  5. Head & Neck (29)
  6. Journal of the National Comprehensive Cancer Network (28)

More Publications

Publishers
  1. American Society of Clinical Oncology (222)
  2. Elsevier Inc. (176)
  3. Oxford University Press (55)
  4. Wiley Blackwell (54)
  5. American Association for Cancer Research (46)
  6. John Wiley & Sons, Inc. (29)

More Publishers

Results (841)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose expansion results of the bifunctional EGFR/TGFβ inhibitor BCA101 with pembrolizumab in patients with recurrent, metastatic head and neck squamous cell carcinoma
    Meeting Abstract

    Hanna, G. J.; Kaczmar, J. M.; Zandberg, D. P.; Wong, D. J. L.; Yilmaz, E.; Sherman, E. J.; Hernando-Calvo, A.; Sacco, A. G.; Chung, C. H.; Bohr, D.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation and expansion study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, given as monotherapy and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer
    Meeting Abstract

    Chung, C. H.; Colevas, A. D. D.; Adkins, D.; Rodriguez, C. P.; Park, J. C.; Gibson, M. K.; Burtness, B.; Johnson, F. M.; Julian, R. A.; Saba, N. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Wong, W.; Cracchiolo, J. R.; Riaz, N.; Ganly, I.; Sherman, E. J.; Ho, A. L.; Morris, L.; Ghossein, R. A.; Haque, S.; Hung, K. W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Dose optimization of novel BRAF inhibitor FORE8394 based on PK and efficacy results
    Meeting Abstract

    Sherman, E. J.; De La Fuente, M. I.; Yaeger, R.; Tsai, F. Y.C.; Janku, F.; Butowski, N. A.; Allen, C. E.; Ammakkanavar, N. R.; Taylor, J. W.; Samara, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid and CNS tumors: Results from a phase 1/2a study
    Meeting Abstract

    De La Fuente, M. I.; Rodon Ahnert, J.; Yaeger, R.; Tsai, F. Y. C.; Janku, F.; Butowski, N. A.; Allen, C. E.; Ammakkanavar, N. R.; Taylor, . W.; Michelson, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • RET-altered cancers—A tumor-agnostic review of biology, diagnosis and targeted therapy activity
    Review

    Desilets, A.; Repetto, M.; Yang, S. R.; Sherman, E. J.; Drilon, A.
    Cancers (2023)

    Fulltext@MSK | Save
  • Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer
    Journal Article

    Han, J.; Zakeri, K.; Raab, G.; Hesse, J.; Shamseddine, A.; Chen, L.; Yu, Y.; Kang, J. J.; McBride, S. M.; Riaz, N.; more...
    Head & Neck (2023)

    Fulltext@MSK | Save
  • The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
    Journal Article

    Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironment
    Journal Article

    Chen, L.; Lee, N.; Sarkar, R.; Katabi, N.; Li, Y.; Morris, L.; Wong, R.; Sherman, E.; Reis-Filho, J. S.; Hollmann, T.; more...
    OncoImmunology (2023)

    Fulltext@MSK | Save